Metro Healthcare Valuation

CARE Stock  IDR 170.00  5.00  3.03%   
At this time, the firm appears to be fairly valued. Metro Healthcare Ind secures a last-minute Real Value of 176.71 per share. The latest price of the firm is 170.0. Our model forecasts the value of Metro Healthcare Ind from analyzing the firm fundamentals such as Profit Margin of (0.40) %, return on equity of -0.0284, and Current Valuation of 14.97 T as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
170.00
Please note that Metro Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Metro Healthcare Ind is based on 3 months time horizon. Increasing Metro Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Metro Healthcare's intrinsic value may or may not be the same as its current market price of 170.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  170.0 Real  176.71 Hype  170.0 Naive  192.0
The intrinsic value of Metro Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Metro Healthcare's stock price.
153.00
Downside
176.70
Real Value
180.15
Upside
Estimating the potential upside or downside of Metro Healthcare Indonesia helps investors to forecast how Metro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Metro Healthcare more accurately as focusing exclusively on Metro Healthcare's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
117.41146.29175.16
Details
Hype
Prediction
LowEstimatedHigh
166.55170.00173.45
Details
Naive
Forecast
LowNext ValueHigh
188.55192.00195.44
Details

Metro Healthcare Total Value Analysis

Metro Healthcare Indonesia is currently forecasted to have takeover price of 14.97 T with market capitalization of 15.56 T, debt of 177.46 B, and cash on hands of 1.22 T. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Metro Healthcare fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
14.97 T
15.56 T
177.46 B
1.22 T

Metro Healthcare Investor Information

About 58.0% of the company shares are held by company insiders. The book value of Metro Healthcare was currently reported as 96.76. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Metro Healthcare's historical financial statements, Metro Healthcare Indonesia is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

Metro Healthcare Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Metro suggests not a very effective usage of assets in November.

Metro Healthcare Ownership Allocation

Metro Healthcare Ind maintains a total of 33.25 Billion outstanding shares. Metro Healthcare Indonesia holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Metro Healthcare Profitability Analysis

The company reported the revenue of 290.93 B. Net Income was 6.1 B with profit before overhead, payroll, taxes, and interest of 144.45 B.

About Metro Healthcare Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Metro Healthcare Indonesia. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Metro Healthcare Ind based exclusively on its fundamental and basic technical indicators. By analyzing Metro Healthcare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Metro Healthcare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Metro Healthcare. We calculate exposure to Metro Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Metro Healthcare's related companies.
PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Anugrah Kasih Rajawali. Metro Healthcare operates under Medical Care Facilities classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 9 people.

8 Steps to conduct Metro Healthcare's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Metro Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Metro Healthcare's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Metro Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Metro Healthcare's revenue streams: Identify Metro Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Metro Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Metro Healthcare's growth potential: Evaluate Metro Healthcare's management, business model, and growth potential.
  • Determine Metro Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Metro Healthcare's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Other Information on Investing in Metro Stock

Metro Healthcare financial ratios help investors to determine whether Metro Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metro with respect to the benefits of owning Metro Healthcare security.